Insider Shareholders with Direct Ownership of Akero Therapeutics, Inc. (AKRO)
This section provides a comprehensive overview of the insiders with direct ownership of Akero Therapeutics, Inc. (AKRO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Akero Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Andrew Cheng
President and CEO |
1,251,849 | 925,351 | 654,324 $29.3 Million | 89 |
Mar 12, 2025
Reduced 0.26%
|
|
Jonathan Young
Chief Operating Officer |
369,327 | 355,354 | 200,540 $8.99 Million | 55 |
Mar 12, 2025
Reduced 0.3%
|
|
Timothy Rolph
Chief Scientific Officer |
234,426 | 318,143 | 169,721 $7.61 Million | 43 |
Mar 12, 2025
Reduced 0.3%
|
| 0 | 169,065 | 136,301 $6.11 Million | 5 |
Nov 30, 2022
Reduced 3.39%
|
|
|
Catriona Yale
Chief Development Officer |
320,361 | 390,508 | 95,034 $4.26 Million | 64 |
Mar 12, 2025
Reduced 0.64%
|
|
William Richard White
Chief Financial Officer |
558,081 | 498,154 | 61,959 $2.78 Million | 56 |
Mar 12, 2025
Reduced 1.08%
|
|
Patrick Lamy
Senior VP, Commercial Strategy |
41,425 | 8,494 | 33,492 $1.5 Million | 11 |
Mar 03, 2025
Reduced 2.9%
|
|
Scott A. Gangloff
Chief Technology Officer |
24,300 | 0 | 24,300 $1.09 Million | 1 |
Dec 16, 2024
Added 50.0%
|
| 26,000 | 26,000 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
| 40,000 | 40,000 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
|
Apple Tree Partners Iv, L.P.
> 10% Shareholder |
0 | 5,830,203 | 0 $0 | 1 |
Jun 28, 2021
Reduced 100.0%
|